About

years

Innovation & Customization

Weintegrated R &D, production, sales and training services for a highly efficient and optimalmanufacturing corporation.

8 fully automated production lines
the production standard is C+A /ISO 7+ISO 5 clean factory
all production processes adopt water for injection (WFI)

50+

R&d Patents

5000m+

Large Factory

12000+

AC/MAC Cooperate

10000+100 level

Clean Workshop

Medical

The product's manufacturing standards and efficacy meet medical-grade standards.

Professional

It holds 47 patents and certifications including ISO, FDA, and CPNP.

Clean

The automated production line and sterile workshop exceed the pharmaceutical-grade GMP standards (100,000-level).

Vegan

The core ingredient is produced using gene fermentation technology, not extracted from animal sources.

Continue exploring and moving forward

2000

Our founder transitioned from clinical medicine to entrepreneurship, launching our journey in the pharmaceutical marketing sector.

2000

2004

Established our first company, focusing on drug registration & approval services and nationwide distribution of new and specialty pharmaceuticals in China.

2004

2013

Founded our second subsidiary to expand into recombinant human albumin cosmetics. We also became the first enterprise in China to achieve nationwide commercial sales of recombinant humanized collagen Class II medical functional dressings.

2013

2017

Completed the acquisition of our third subsidiary — a nationally certified high-tech enterprise and the first company in China dedicated to the R&D, manufacturing and full-chain distribution of Class III medical collagen patch dressings.

2017

2018

Won the title of "National Double Love and Double Evaluation Advanced Enterprise Union" again; the 100,000-ton/year new energy material (dimethyl carbonate) production unit was put into operation, entering the lithium battery raw material supply chain.

2018

2020

Built our self-owned production base in Shandong Province, covering the full industrial chain of technology development, clinical research, manufacturing and sales for recombinant humanized collagen, functional skincare, medical devices, and 3D printing of low-temperature regenerative biomedical materials.

2020

2023

Launched our global expansion strategy and officially rolled out product sales in overseas markets.

2023

2025

Relocated our group headquarters to Beijing Life Science Park, opening a new chapter of corporate growth.

2025

2000

2004

2013

2017

2018